Status:
UNKNOWN
Saxon SARS-CoV-2 Infection and Vaccination Study in Dialysis Patients, Solid Organ Recipients and Staff
Lead Sponsor:
Technische Universität Dresden
Collaborating Sponsors:
Universitätsklinikum Leipzig
Klinikum St. Georg gGmbH
Conditions:
SARS-CoV-2 Infection
Active Immunization
Eligibility:
All Genders
18-100 years
Brief Summary
To investigate short- (3 and 8 weeks) and long-term (6, 9, 12, and 18 months) immune protection or response at the humoral and cellular levels before and after SARS-CoV-2 infection or vaccination in p...
Detailed Description
* Formation of two separate cohorts of approximately 1000 study subjects each from the three categories (dialysis patients, solid organ transplant recipients and medical staff) of participants vaccina...
Eligibility Criteria
Inclusion
- Dialysis patients, organ transplant recipients and medical staff
- written consent to participate in the study
Exclusion
- Age \< 18 years old
Key Trial Info
Start Date :
January 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
3500 Patients enrolled
Trial Details
Trial ID
NCT04799808
Start Date
January 15 2021
End Date
December 31 2023
Last Update
August 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Univercity Hospital Carl Gustav Carus
Dresden, Saxony, Germany, 01307